Search Press releases Keywords From To 8 Nov 2022 UCB Reinforces Commitment to Rheumatology with 15 Abstracts including New Late-Breaking Data at ACR Convergence 2022 Read More 13 Oct 2022 UCB announces positive preliminary results for major brivaracetam (Briviact[®]) study in Asia Read More 27 Sep 2022 FINTEPLA[®▼] (fenfluramine) Approved in Japan for the Treatment of Seizures Associated with Dravet Syndrome Read More 23 Sep 2022 Disposal of own shares Read More 22 Sep 2022 UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting Read More 20 Sep 2022 European Medicine Agency Accepts Marketing Authorization Applications for Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis Read More Pagination First page Previous page Previous … Page 29 Page 30 Page 31 Page 32 Current page 33 Page 34 Page 35 Page 36 Page 37 … Page 33 of 70 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
